Management of advanced breast cancer with the epothilone B analog, ixabepilone

por Gradishar, William
Publicado 2009

Treatment challenges for community oncologists treating postmenopausal women with endocrine-resistant, hormone receptor-positive, human epidermal growth factor receptor 2-negative...

por Gradishar, William J
Publicado 2016

Differences Are Important: Breast Cancer Therapy in Different Ethnic Groups

por Costa, Ricardo L.B., Gradishar, William J.
Publicado 2017

In Reply

por Gradishar, William, Brown, Krystal, Mundt, Erin, Manley, Susan
Publicado 2017

nab-Paclitaxel for first-line treatment of patients with metastatic breast cancer and poor prognostic factors: a retrospective analysis

por O’Shaughnessy, Joyce, Gradishar, William J., Bhar, Paul, Iglesias, Jose
Publicado 2013

ERK-regulated αB-Crystallin Induction by Matrix Detachment Inhibits Anoikis and Promotes Lung Metastasis in vivo

por Malin, Dmitry, Strekalova, Elena, Petrovic, Vladimir, Rajanala, Harisha, Sharma, Bhawna, Ugolkov, Andrey, Gradishar, William J., Cryns, Vincent L.
Publicado 2015

Study design and protocol for tailored Acceptance and Commitment Therapy (ACT) to optimize quality of life in women living with metastatic breast cancer()

por Moreno, Patricia I., Horner, Fiona S., Torzewski, Joanna B., Thomas, Jessica L., Gradishar, William, Victorson, David, Penedo, Frank J.
Publicado 2021

Role of Fcγ receptors in HER2-targeted breast cancer therapy

por Musolino, Antonino, Gradishar, William J, Rugo, Hope S, Nordstrom, Jeffrey L, Rock, Edwin P, Arnaldez, Fernanda, Pegram, Mark D
Publicado 2022

LPTO-02. INTRATHECAL (IT) TRASTUZUMAB (T) FOR THE TREATMENT OF LEPTOMENINGEAL DISEASE (LM) IN PATIENTS (PTS) WITH HUMAN EPIDERMAL RECEPTOR-2 POSITIVE (HER2+) CANCER: A MULTICENTER...

por Kumthekar, Priya, Lassman, Andrew B, Lin, Nancy, Grimm, Sean, Gradishar, William, Pentsova, Elena, Jeyapalan, Suriya, Groves, Morris, Melisko, Melissa, Raizer, Jeffrey
Publicado 2019

A phase 3 tRial comparing capecitabinE in combination with SorafenIb or pLacebo for treatment of locally advanced or metastatIc HER2-Negative breast CancEr (the RESILIENCE study):...

por Baselga, José, Costa, Frederico, Gomez, Henry, Hudis, Clifford A, Rapoport, Bernardo, Roche, Henri, Schwartzberg, Lee S, Petrenciuc, Oana, Shan, Minghua, Gradishar, William J
Publicado 2013

Developmental therapeutics for inflammatory breast cancer: Biology and translational directions

por Costa, Ricardo, Santa-Maria, Cesar A, Rossi, Giovanna, Carneiro, Benedito A, Chae, Young Kwang, Gradishar, William J, Giles, Francis J, Cristofanilli, Massimo
Publicado 2016

A novel small-molecule antagonizes PRMT5-mediated KLF4 methylation for targeted therapy

por Zhou, Zhuan, Feng, Zhiwei, Hu, Dong, Yang, Peng, Gur, Mert, Bahar, Ivet, Cristofanilli, Massimo, Gradishar, William J., Xie, Xiang-qun, Wan, Yong
Publicado 2019

Phase II study of pembrolizumab and capecitabine for triple negative and hormone receptor-positive, HER2−negative endocrine-refractory metastatic breast cancer

por Shah, Ami N, Flaum, Lisa, Helenowski, Irene, Santa-Maria, Cesar A, Jain, Sarika, Rademaker, Alfred, Nelson, Valerie, Tsarwhas, Dean, Cristofanilli, Massimo, Gradishar, William
Publicado 2020

Analyses of selected safety endpoints in phase 1 and late-phase clinical trials of anti-PD-1 and PD-L1 inhibitors: prediction of immune-related toxicities

por Costa, Ricardo, Costa, Rubens B., Talamantes, Sarah M., Helenoswki, Irene, Carneiro, Benedito A., Chae, Young Kwang, Gradishar, William J., Kurzrock, Razelle, Giles, Francis J.
Publicado 2017

Evaluation of the 12-Gene Molecular Score and the 21-Gene Recurrence Score as Predictors of Response to Neo-adjuvant Chemotherapy in Estrogen Receptor-Positive, HER2-Negative Breas...

por Soliman, Hatem, Wagner, Susanne, Flake, Darl D., Robson, Mark, Schwartzberg, Lee, Sharma, Priyanka, Magliocco, Anthony, Kronenwett, Ralf, Lancaster, Johnathan M., Lanchbury, Jerry S., Gutin, Alexander, Gradishar, William
Publicado 2020

Predicting Expected Absolute Chemotherapy Treatment Benefit in Women With Early-Stage Breast Cancer Using EndoPredict, an Integrated 12-Gene Clinicomolecular Assay

por Soliman, Hatem, Flake, Darl D., Magliocco, Anthony, Robson, Mark, Schwartzberg, Lee, Sharma, Priyanka, Brown, Krystal, Wehnelt, Saskia, Kronenwett, Ralf, Gutin, Alexander, Lancaster, Johnathan, Cuzick, Jack, Gradishar, William
Publicado 2019

A Technology-Based Physical Activity Intervention for Patients With Metastatic Breast Cancer (Fit2ThriveMB): Protocol for a Randomized Controlled Trial

por Phillips, Siobhan, Solk, Payton, Welch, Whitney, Auster-Gussman, Lisa, Lu, Marilyn, Cullather, Erin, Torre, Emily, Whitaker, Madelyn, Izenman, Emily, La, Jennifer, Lee, Jungwha, Spring, Bonnie, Gradishar, William
Publicado 2021

Association of a novel circulating tumor DNA next-generating sequencing platform with circulating tumor cells (CTCs) and CTC clusters in metastatic breast cancer

por Davis, Andrew A., Zhang, Qiang, Gerratana, Lorenzo, Shah, Ami N., Zhan, Youbin, Qiang, Wenan, Finkelman, Brian S., Flaum, Lisa, Behdad, Amir, Gradishar, William J., Platanias, Leonidas C., Cristofanilli, Massimo
Publicado 2019

Positive predictive value of ERBB2 copy number gain by tissue or circulating tumor DNA next-generation sequencing across advanced cancers

por Shah, Ami N., Sunderraj, Ashwin, Finkelman, Brian, See, Sharlene H., Davis, Andrew A., Gerratana, Lorenzo, Wehbe, Firas, Katam, Neelima, Mahalingam, Deva, Gradishar, William J., Behdad, Amir, Blanco, Luis, Cristofanilli, Massimo
Publicado 2022

Prediction of chemotherapy benefit by EndoPredict in patients with breast cancer who received adjuvant endocrine therapy plus chemotherapy or endocrine therapy alone

por Sestak, Ivana, Martín, Miguel, Dubsky, Peter, Kronenwett, Ralf, Rojo, Federico, Cuzick, Jack, Filipits, Martin, Ruiz, Amparo, Gradishar, William, Soliman, Hatem, Schwartzberg, Lee, Buus, Richard, Hlauschek, Dominik, Rodríguez-Lescure, Alvaro, Gnant, Michael
Publicado 2019